|
|
Controversies in Obstetrics, Gynecology & Infertility (COGI)
November 27 - 30, 2008, Paris, France |
|
| |
| Infertility & ART (I) |
|
|
| Thursday, November 27, 2008 |
18:30-20:00 Welcome Reception
at the Le Meridien Montparnasse Hotel |
|
|
Friday, November 28, 2008 |
|
|
| 08:30-10:00 |
Plenary Session
Keynote Lecture: Advances in Ob/Gyn and Infertility
LEADERS' VIEW ON THE FUTURE |
|
Capsule: |
Technology-based diagnosis allows better and minimally-invasive treatments; What the future holds for our main sub-disciplines? |
|
Chairpersons:
|
Z. Ben Rafael, Israel
G.C. Di Renzo, Italy
R. Frydman, France
Z. Shoham, Israel
|
| 08:30-09:00 |
Feto-Maternal medicine
The future of prenatal diagnosis. Invasive or non Invasive?
K. Nicolaides, UK
|
| 09:00-09:30 |
Gynecology
The future of endoscopic surgery and the future surgeon. Robots with brain! C. Nezhat, USA
|
| 09:30-10:00 |
Infertility
ART: Reflecting on its future
J. Cohen, USA
|
|
10:00-10:30
|
Coffee break
|
| 10:30-12:30 |
MILD STIMULATION FOR IVF |
|
Organized and endorsed by the International Society for Mild Approaches in Assisted Reproduction (ISMAAR) |
|
Capsule: |
Results of monofollicular stimulation per initiated cycle are too low and dropout is too high to make it a viable option for routine IVF! |
|
Chairpersons:
|
R. Frydman, France
G. Nargund, UK |
| 10:30-11:15 |
Debate: Mild/Modified Natural Cycle IVF Should be the Way Forward With the Introduction of Single Embryo Transfer (SET)
|
|
|
|
11:15-12:00 |
Debate: To Achieve the Maximum Benefit. In Vitro Maturation (IVM) Cycle Should be Combined with Natural Cycle IVF in Ovulatory Women
No: S. Lindenberg, Sweden
Yes: R.C. Chian, Canada
Discussion
|
|
12:00-12:30 |
|
|
12:30-13:30
|
Lunch break
|
|
13:30-15:30 |
ROUND TABLE DISCUSSION: CLINICAL ASPECTS OF ART |
|
Capsule: |
Expert opinion and audience interaction on controversial clinical aspects of ART
|
| Chairpersons: |
Z. Ben Rafael, Israel
J. Belaisch-Allart, France
|
|
Panellists:
|
S. Daya, Canada
P.G. Crosignani, Italy
K. Diedrich, Germany
N. Gleicher, USA
R. Frydman, France
|
|
Discussion: |
Questions to the panelists:
Should we omit all treatments and move directly to IVF?
Natural cycles for IVF, or mild stimulation?
Starting dose of gonadotropins: Low or regular?
Is there evidence to support the routine use of oral contraceptives in ART cycles?
Why did the antagonist not replace the agonist?
Do we need the addition of luteinizing hormone (LH) for ovarian stimulation?
Intra Cytoplasmic Sperm Injection (ICSI) for all patients?
Assisted zona hatching: Should we keep doing it?
How can embryo transfer be improved?
Should we routinely support the luteal phase with progesterone, aspirin or estradiol?
|
|
15:30-16:00
|
Coffee break
|
|
|
ASSESSMENT OF OVARIAN RESERVE |
| Capsule:cussion: |
Decreased ovarian reserve remains a common and frustrating problem despite years of experience. Can we evaluate and provide better treatment? |
|
Chairpersons:
|
P.G. Crosignani, Italy
J. Blankstein, USA
|
| 16:00-16:15 |
|
| 16:15-16:55 |
Debate: Anti-Mullerian Hormone (AMH) or Antral Follicle Count: Which should be the Gold Standard for Evaluation of the Ovarian Follicular Status in 2008?
AMH is superior!
|
| 16:55-17:15 |
What should be the first-line treatment for unexplained infertility in women over 40 years of age: Superovulation and IUI, or IVF?
N. Laufer, Israel
|
|
17:15-18:00 |
Proposition: No treatment options for Decreased Ovarian Reserve and Low Responders are effective. It is only cycle-to-cycle variation that is of importance!
P. Patrizio, USA
Opposition: Better protocols will result in better pregnancy rates!
M. Surrey, USA
Discussion
|
|
Saturday, November 29, 2008 |
|
|
This section is being organized and endorsed by Serono Symposia International Foundation (SSIF)
Conference Celebrate 30 years of IVF: New Technology in Reproductive Medicine
|
|
08:15-08:20
|
Welcome from SSIF
J-D. Baki, SSIF Board of Directors
R. Fischer, Germany
|
| 08:20-08:30 |
Introductions to the Conference
Z. Shoham, Israel
|
|
|
|
08:30-10:00 |
STEM CELLS FOR REPRODUCTIVE AND REGENERATIVE MEDICINE |
|
Capsule: |
Organized and endorsed by Serono Symposia International Foundation Stem-cell-based medicine: What are the expectations? What is feasible?
|
|
Chairpersons:on
: |
Y. Verlinsky, USA
G.P. Palermo, USA
N. Frydman, France
|
|
08:30-09:00
|
Where are we now in the understanding of endometrial stem cells?
C. Simón, Spain
|
|
09:00-09:30
|
Can stem cells serve as a source of gametes?
A. Marques, Spain
|
|
09:30-10:00 |
Reprogramming as a new approach to obtain patient-specific stem cells
R. Ensenat-Waser, Spain
|
|
10:00-10:30
|
Coffee break
|
| 10:30-12:30 |
IN VITRO MATURATION (IVM) |
|
Organized and endorsed by Serono Symposia International Foundation |
|
Capsule: |
IVM is becoming more effective: Benefits, risk and pitfalls of the procedure
|
| Chairpersons: |
R. Frydman, France
H.I. Nielsen, Denmark
A. Weissman, Israel
|
|
10:30-11:10 |
Debate: Can IVM Now be Offered as a Treatment?
IVM is ready as a treatment for PCOS patients
M. Leong, Hong Kong
IVM is not ready as a treatment
K.R. Held, Germany
Discussion
|
|
|
|
11:10-11:50 |
Debate: What is the Optimum Preparation for IVM?
FSH priming for IVM
A.L. Mikkelsen, Denmark
hCG priming for IVM
R.C. Chian, Canada
Discussion
|
|
|
|
|
Debate: IVM and Fertility Preservation
The role of IVM in the preservation of fertility
S.L. Tan, Canada
Efficiency of IVM treatment
R. Fadini, Italy
Discussion
|
|
12:30-13:30
|
Lunch break
|
| 13:30-15:30 |
CRYOPRESERVATION OF GAMETES AND OVARIAN TISSUE |
|
Organized and endorsed by Serono Symposia International Foundation |
|
Capsule: |
The optimum method for cryopreserving oocytes and ovarian tissue is yet to be decided
|
|
Chairpersons: |
Z. Rosenwaks, USA
P. Patrizio, USA
C. Poirot, France
|
|
13:30-14:00
|
What do we know and what is our future course?
R. Gosden, USA |
|
14:00-15:30 |
Debate: What are the Best Methods for the Cryopreservation of Human Oocytes?
Human oocyte cryopreservation: The slow freezing technique
A. Borini, Italy
Autotransplantation of frozen human ovarian tissue and follicles
J. Donnez, Belgium
Whole ovary cryopreservation and transplantation in sheep
B. Salle, France
Discussion
|
|
15:30-16:00 |
Coffee break
|
|
|
NEW CRYOTECHNOLOGIES FOR GAMETES, OVARIAN TISSUE AND STEM CELLS |
|
Organized and endorsed by Serono Symposia International Foundation |
|
Capsule: |
New cryopreservation technologies can enhance clinical results
|
|
Chairpersons:
|
R. Gosden, USA
A. Arav, Israel
J. Dor, Israel |
|
16:00-16:30
|
Human oocyte cryopreservation: Vitrification techniques
J. Liebermann, USA |
| 16:30-16:50 |
Freezing whole human ovaries
P. Patrizio, USA |
| 16:50-17:10 |
Freezing/drying of spermatozoa
J. Biggers, USA |
| 17:10-17:50 |
Freeze/drying of stem cells
A. Arav, Israel
|
| 17:30-18:05 |
SPECIAL LECTURE IN HONOUR OF PROF. ROBERT EDWARDS, UK
|
|
Chairpersons: |
V. Gomel, Canada
R. Frydman, France
|
|
Reproductive medicine in the era of the personal genome
A. Handyside, UK
|
|
|
|
Sunday, November 30, 2008 |
|
|
| 08:30-10:00 |
CONTROLLED OVARIAN STIMULATION |
|
Sponsored in part by an unrestricted grant from Ferring France |
|
Capsule: |
Is there a relationship between follicle growth and cocyte-cumulus complex? What is the clinical implication? |
|
Chairperson:
|
R. Gosden, USA
C. Simon, Spain
J.F. Velez De La Calle, France
|
|
08:30-09:00
|
|
|
09:00-09:30
|
Oocyte morphology and outcome: Lessons from IVF
N. Frydman, France |
|
09:30-10:00
|
|
|
10:00-10:30
|
|
| 10:30-12:30 |
POLYCYSTIC OVARIAN SYNDROME (PCOS) |
|
Supported by International society of IVF (ISIVF) |
|
Capsule: |
PCOS is a risk factor for insulin resistance: Are all PCOS patients at risk?
|
|
Chairpersons:
|
P.Patrizio, USA
J.N. Hugues, France
A. Requena, Spain
|
|
10:30-11:00
|
|
| 11:00-11:45 |
Debate: Should Metformin be Routinely Used in Infertile Patients with PCOS?
Yes: S. Daya, Canada
Cons: Systemic review does not show consistent effect!
P. Bouchard, France
Discussion
|
|
|
| 11:45-12:30 |
Debate: Treating Anovulatory PCOS Patient; What should be the First Choice?
Ovulation induction?
S. Daya, Canada
Ovarian Drilling?
H. Fernandez, France
IVM
S.L. Tan, Canada
Discussion
|
|
|
|
|
WebStudio.co.il